Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): Long Term Results of a “Donor” Versus “No Donor” Comparison.

Mohamad Mohty, MD, PhD, Hugues de Lavallade, MD, Jean El-Cheikh, MD, Patrick Ladaique, MD, Catherine Faucher, MD, Sabine Furst, MD, Norbert Vey, MD, Diane Coso, MD, Anne-Marie Stoppa, MD, Jean-Albert Gastaut, MD, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2007) 110 (11): 1090.

https://doi.org/10.1182/blood.V110.11.1090.1090

Published: 2007

Journal Articles

Prior High Dose Chemotherapy and a Higher “Intensity” of the Preparative Regimen Can Influence Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Mohamad Mohty, MD, PhD, Xavier Cahu, Catherine Faucher, MD, Patrice Chevallier, MD, Norbert Vey, MD, Jean El-Cheikh, MD, Thierry Guillaume, MD, Sabine Furst, MD, Jacques Delaunay, MD, Hugues de Lavallade, MD, Philippe Moreau, MD, Jean-Albert Gastaut, MD, Jean-Luc Harousseau, MD, Didier Blaise, MD

Blood (2007) 110 (11): 2001.

https://doi.org/10.1182/blood.V110.11.2001.2001

Published: 2007

Journal Articles

Good Safety and Tolerance Profiles of Long Term Treatment of Advanced Multiple Myeloma (MM) with Bortezomib.

Jean El-Cheikh, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, MD, Diane Coso, MD, Jean-Marc Schiano de Collela, MD, Therese Aurran, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2007) 110 (11): 4811.

https://doi.org/10.1182/blood.V110.11.4811.4811

Published: 2007

Journal Articles

Autologous Stem Cell Transplantation (auto-SCT) in Elderly Patients with Multiple Myeloma (MM): Age per se Does Not Affect Outcome.

Jean El-Cheikh, MD, Elias Kfoury, MD, Christian Chabannon, MD, PhD, Anne-Marie Stoppa, MD, Reda Bouabdallah, MD, Diane Coso, MD, Jean-Marc Schiano de Collela, MD, Vadim Ivanov, MD, Therese Aurran, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2007) 110 (11): 947.

https://doi.org/10.1182/blood.V110.11.947.947

Published: 2007

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Refractory or Relapsed Non-Hodgkin’s Lymphoma (NHL).

Hugues de Lavallade, MD, Reda Bouabdallah, MD, Catherine Faucher, MD, Sabine Furst, MD, Jean El-Cheikh, MD, Norbert Vey, MD, Anne-Marie Stoppa, MD, Danielle Sainty, MD, Christine Arnoulet, Luc Xerri, MD, Philippe Cassier, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2006) 108 (11): 5356.

https://doi.org/10.1182/blood.V108.11.5356.5356

Published: 2006

Journal Articles

Plasma Proteomic Profiles May Predict Early Acute Graft-vs.-Host Disease (aGVHD) Following Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

Mohamad Mohty, MD, PhD, Anthony Goncalves, MD,PhD, Benjamin Esterni, PhD, Yves Toiron, Beatrice Gaugler, PhD, Catherine Faucher, MD, Jean El-Cheikh, MD, Sabine Furst, MD, Jean-Albert Gastaut, MD, Patrice Viens, MD, Daniel Olive, MD,PhD, Christian Chabannon, MD,PhD, Jean-Paul Borg, PhD, Didier Blaise, MD

Blood (2006) 108 (11): 2880.

https://doi.org/10.1182/blood.V108.11.2880.2880

Published: 2006

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

Hugues de Lavallade, MD, Patrick Ladaique, MD, Catherine Faucher, MD, Sabine Furst, MD, Jean El-Cheikh, MD, Anne-Marie Stoppa, MD, Diane Coso, MD, Reda Bouabdallah, MD, Norbert Vey, MD, Danielle Sainty, MD, Christian Chabannon, MD, PhD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2006) 108 (11): 3003.

https://doi.org/10.1182/blood.V108.11.3003.3003

Published: 2006

Journal Articles

Long Term Infectious Complications Following Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

Anne Etienne, MD, Mohamad Mohty, MD, PhD, Catherine Faucher, MD, Sabine Furst, MD, Jean El-Cheikh, MD, Christine Zandotti, MD, Pierre Berger, MD, Norbert Vey, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, MD, Patrice Viens, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD

Blood (2006) 108 (11): 2850.

https://doi.org/10.1182/blood.V108.11.2850.2850

Published: 2006

Journal Articles

Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation (allo-SCT).

Thomas Prebet, MD, Mohamad Mohty, MD, PhD, Patrick Ladaique, MD, Christian Chabannon, MD,PhD, Catherine Faucher, MD, Sabine Furst, MD, Hugues de Lavallade, MD, Jean El-Cheikh, MD, Patrice Viens, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD

Blood (2006) 108 (11): 2989.

https://doi.org/10.1182/blood.V108.11.2989.2989

Published: 2006

Journal Articles

Features and Risk Factors of Peripheral Neuropathy during Treatment of Advanced Multiple Myeloma with Bortezomib.

Jean El-Cheikh, MD, Anne Marie Stoppa, MD, Segolene Duran, Reda Bouabdallah, MD, Norbert Vey, MD, Diane Coso, MD, Vadim Ivanov, MD, Aude Charbonnier, MD, Catherine Faucher, MD, Jean Marc Schiano de Collela, MD, Jacques Camerlo, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2006) 108 (11): 5098.

https://doi.org/10.1182/blood.V108.11.5098.5098

Published: 2006

NARROW

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): Long Term Results of a “Donor” Versus “No Donor” Comparison.

Prior High Dose Chemotherapy and a Higher “Intensity” of the Preparative Regimen Can Influence Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Good Safety and Tolerance Profiles of Long Term Treatment of Advanced Multiple Myeloma (MM) with Bortezomib.

Autologous Stem Cell Transplantation (auto-SCT) in Elderly Patients with Multiple Myeloma (MM): Age per se Does Not Affect Outcome.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Refractory or Relapsed Non-Hodgkin’s Lymphoma (NHL).

Plasma Proteomic Profiles May Predict Early Acute Graft-vs.-Host Disease (aGVHD) Following Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

Long Term Infectious Complications Following Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

Platelets Recovery and Transfusion Needs after Reduced Intensity Conditioning (RIC) Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation (allo-SCT).

Features and Risk Factors of Peripheral Neuropathy during Treatment of Advanced Multiple Myeloma with Bortezomib.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only